About Circle of Life

Half my life is mirrored in the River Cam; the other half is pinned to a lab whiteboard bristling with untested hypotheses. Having turned a Cambridge PhD into a lifestyle, I've found that clinical trial data reads better than most novels. I'm still here — mostly because the questions remain far more seductive than the answers.

Circle of Life exists because I found existing biotech content either too shallow or too fragmented — no platform offered expert-level analysis from someone inside the lab, with multidisciplinary insights in both Chinese and English.

What I Cover

• 🫀 Metabolic & Liver Disease: MASH/MASLD, GLP-1 applications, novel targets
• 🧠 Neuroscience: Brain-computer interfaces, neurodegeneration, neuromodulation
• 💊 Drug Pipelines: FDA decisions, clinical data readouts, industry dynamics
• 🔬 Longevity Biology: Senolytics, epigenetic reprogramming, aging clocks

My Philosophy

Hot topics have many interpreters. My edge is a researcher's skepticism: I'll tell you when a "breakthrough" is overhyped, which targets are undervalued, and what the data actually says versus what the press release claims.

Get in Touch

Reach me via email. I welcome collaborations, guest perspectives, and reader questions.